Joint Effect of Insulin-like Growth Factors and Sex Steroids on Breast Cancer Risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 10, 2003, Pages 1067-1073

  Yu, Herbert ^a,e   Shu, Xiao Ou ^b   Li, Benjamin D L ^c   Dai, Qi ^b   Gao, Yu Tang ^d   Jin, Fan ^d   Zheng, Wei ^b  

^a YALE CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

^d SHANGHAI CANCER INSTITUTE   (China)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTRADIOL; ESTROGEN; ESTRONE; ESTRONE SULFATE; MITOGENIC AGENT; PRASTERONE SULFATE; SEX HORMONE; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TESTOSTERONE;

ADULT; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RISK; CELL DIFFERENTIATION; CELL GROWTH; CHINA; CONDITIONAL LOGISTIC REGRESSION ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; HUMAN CELL; IMMUNOASSAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PATHOGENESIS; POPULATION RESEARCH; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SIGNAL TRANSDUCTION;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; SOMATOMEDINS; TESTOSTERONE;

EID: 0142212203     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Brewster, A., and Helzlsouer, K. Breast cancer epidemiology, prevention, and early detection. Curr. Opin. Oncol., 13: 420-425, 2001.
2. Flototto, T., Djahansouzi, S., Glaser, M., Hanstein, B., Niederacher, D., Brumm, C., and Beckmann, M. W. Hormones and hormone antagonists: mechanisms of action in carcinogenesis of endometrial and breast cancer. Horm. Metab. Res., 33: 451-457, 2001.
3. Beckmann, M. W., Niederacher, D., Schnurch, H. G., Gusterson, B. A., and Bender, H. G. Multistep carcinogenesis of breast cancer and tumour heterogeneity. J. Mol. Med., 75: 429-439, 1997.
4. Sachdev, D., and Yee, D. The IGF system and breast cancer. Endocr. Relat. Cancer, 8: 197-209, 2001.
5. Ellis, M. J., Jenkins, S., Hanfelt, J., Redington, M. E., Taylor, M., Leek, R., Siddle, K., and Harris, A. Insulin-like growth factors in human breast cancer. Breast Cancer Res. Treat., 52: 175-184, 1998.
6. Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., and Pollak, M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet, 351: 1393-1396, 1998.
7. Toniolo, P., Bruning, P. F., Akhmedkhanov, A., Bonfrer, J. M., Koenig, K. L., Lukanova, A., Shore, R. E., and Zeleniuch-Jacquotte, A. Serum insulin-like growth factor-I and breast cancer. Int. J. Cancer, 88: 828-832, 2000.
8. Byrne, C., Colditz, G. A., Willett, W. C,. Speizer, F. E., Pollak, M., and Hankinson, S. E. Plasma insulin-like growth factor (IGF) 1, IGF-binding protein 3, and mammographic density. Cancer Res., 60: 3744-3748, 2000.
9. Yee. D., and Lee, A. V. Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J. Mammary Gland Biol. Neoplasia, 5: 107-115, 2000.
10. Nicholson, R. I., and Gee, J. M. W. Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer. Br. J. Cancer, 82: 501-513, 2000.
11. Thorsen, T., Lahooti, H., Rasmussen, M., and Aakvaag, A. Oestradiol treatment increases the sensitivity of MCF-7 cells for the growth stimulatory effect of IGF-I. J. Steroid Biochem. Mol. Biol., 41: 537-540, 1992.
12. Ruan, W., Catanese, V., Wieczorek, R., Feldman, M., and Kleinberg, D. L. Estradiol enhances the stimulatory effect of insulin-like growth factor-I (IGF-I) on mammary development and growth hormone-induced IGF-I messenger ribonucleic acid. Endocrinology, 136: 1296-1302, 1995.
13. Stewart, A. J., Johnson, M. D., May, F. E., and Westley, B. R. Role of insulin-like growth factors and the type 1 insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J. Biol. Chem., 265: 21172-21178, 1990.
14. Clarke, R. B., Howell, A., and Anderson, E. Type I insulin-like growth factor receptor gene expression in normal human breast tissue treated with oestrogen and progesterone. Br. J. Cancer, 75: 251-257, 1997.
15. Dupont, J., and Le Roith, D. Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects. Mol. Pathol., 54: 149-154, 2001.
16. Owens, P. C., Gill, P. G., de Young, N. J., Weger, M. A., Knowles, S. E., and Moyse, K. J. Estrogen and progesterone regulate secretion of insulin-like growth factor binding proteins by human breast cancer cells. Biochem. Biophys. Res. Commun., 193: 467-473, 1993.
17. Manni, A., Badger, B., Wei, L., Zaenglein, A., Grove, R., Khin, S., Heitjan, D., Shimasaki, S., and Ling, N. Hormonal regulation of insulin-like growth factor II and insulin-like growth factor binding protein expression by breast cancer cells in vivo: evidence for stromal epithelial interactions. Cancer Res., 54: 2934-2942, 1994.
18. Mathieu, M., Vignon, F., Capony, F., and Rochefort, H. Estradiol down-regulates the mannose-6-phosphate/insulin-like growth factor-II receptor gene and induces cathepsin-D in breast cancer cells: a receptor saturation mechanism to increase the secretion of lysosomal proenzymes. Mol. Endocrinol., 5: 815-822, 1991.
19. Huynh, H. T., Tetenes, E., Wallace, L., and Pollak, M. In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen. Cancer Res., 53: 1727-1730, 1993.
20. Guvakova, M. A., and Surmacz, E. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells. Cancer Res., 57: 2606-2610, 1997.
21. El-Tanani, M. K., and Green, C. D. Interaction between estradiol and growth factors in the regulation of specific gene expression in MCF-7 human breast cancer cells. J. Steroid Biochem. Mol. Biol., 60: 269-276, 1997.
22. Hwa, I. A., Reimann, K., Lim, P. K., and Lai, L. C. Effects of insulin-like growth factors I and II on oestrone sulphatase activity in human breast cancer cell lines. Int. J. Mol. Med., 4: 175-178, 1999.
23. Oesterreich, S., Zhang, P., Guler, R. L., Sun, X., Curran, E. M., Welshons, W. V., Osborne, C. K., and Lee, A. V. Re-expression of estrogen receptor α in estrogen receptor α-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. Cancer Res., 61: 5771-5777, 2001.
24. Lee, A. V., Jackson, J. G., Gooch, J. L., Hilsenbeek, S. G., Coronado-Heinsohn, E., Osborne, C. K., and Yee, D. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol. Endocrinol., 13: 787-796, 1999.
25. Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., and Liao, J. K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature (Lond.), 407: 538-541, 2000.
26. Ignar-Trowbridge, D. M., Pimentel, M., Parker, M. G., McLachlan, J. A., and Korach, K. S. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology, 137: 1735-1744, 1996.
27. Gao, Y. T., Shu, X. O., Dai, Q., Potter, J. D., Brinton, L. A., Wen, W. Q., et al. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai breast cancer study. Int. J. Cancer, 87: 295-300, 2000.
28. Toniolo, P. G., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K., Shore, R. E., et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J. Natl. Cancer Inst. (Bethesda), 87: 190-197, 1995.
29. Hankinson, S. E., Willett, W. C., Manson, J. E., Colditz, G. A., Hunter, D. J., Spiegelman, D., et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst. (Bethesda), 90: 1292-1299, 1998.
30. Cauley, J. A., Lucas, F. L., Kuller, L. H., Stone, K., Browner, W., Cummings, S. R., et al. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Ann. Intern. Med., 130: 270-277, 1999.
31. Dorgan, J. F., Longcope, C., Stepphenson, H. E., Jr., Falk, R. T., Miller, R., Franz, C., et al. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol. Biomark. Prev., 5: 533-539, 1996.
32. Berrino, F., Muti, P., Micheli, A., Bolelli, G., Krogh, V., Sciajno, R., et al. Serum sex hormone levels after menopause and subsequent breast cancer. J. Natl. Cancer Inst. (Bethesda), 291-296, 1996.
33. Zeleniuch-Jacquotte, A., Bruning, P. F., Bonfrer, J. M. G., Koenig, K. L., Shore, R. E., Kim, M. Y., et al. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. Am. J. Epidemiol., 145: 1030-1038, 1997.
34. Thomas, H. V., Key, T. J., Allen, D. S., Moore, J. W., Dowsett, M., Fentiman, I. S., et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. Br. J. Cancer, 76: 401-405, 1997.
35. Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl. Cancer Inst. (Bethesda), 94: 606-616, 2002.
36. Goossens, K., Esquenet, M., Swinnen, J. V., Manin, M., Rombauts, W., and Verhoeven, G. Androgens decrease and retinoids increase the expression of insulin-like growth factor-binding protein-3 in LNcaP prostatic adenocarcinoma cells. Mol. Cell. Endocrinol., 155: 9-18, 1999.
37. Gregory, C. W., Kim, D., Ye, P., D'Ercole, A. J., Pretlow, T. G., Mohler, J. L., and French, F. S. Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft. Endocrinology, 140: 2372-2381, 1999.
38. Martin, J. L., and Pattison, S. L. Insulin-like growth factor binding protein-3 is regulated by dihydrotestosterone and stimulates deoxyribonucleic acid synthesis and cell proliferation in LNCaP prostate carcinoma cells. Endocrinology, 141: 2401-2409, 2000.
39. Culig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., and Klocker, H. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res., 54: 5474-5478, 1994.
40. Nickerson, T., Pollak, M., and Huynh, H. Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2, 3, 4 and 5. Endocrinology, 139: 807-810, 1998.
41. Maor, G., Segev, Y., and Phillip, M. Testosterone stimulates insulin-like growth factor-I and insulin-like growth factor-I-receptor gene expression in the mandibular condyle: a model of endochondral ossification. Endocrinology, 140: 1901-1910, 1999.
42. Bergh, C., Carlsson, B., Olsson, J. H., Selleskog, U., and Hillensjo, T. Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil. Steril., 59: 323-331, 1993.
43. Vendola, K., Zhou, J., Wang, J., Famuyiwa, O. A., Bievre, M., and Bondy, C. A. Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol. Reprod., 61: 353-357, 1999.
44. Tissandier, O., Peres, G., Fiet, J., and Piette, F. Testosterone, dehydroepiandrosterone, insulin-like growth factor 1, and insulin in sedentary and physically trained aged men. Eur. J. Appl. Physiol., 85: 177-184, 2001.
45. Janssen, J. A., Stolk, R. P., Pols, H. A., Grobbee, D. E., de Jong, F. H., and Lamberts, S. W. Serum free IGF-I, total IGF-I, IGFBP-I and IGFBP-3 levels in an elderly population: relation to age and sex steroid levels. Clin. Endocrinol. (Oxf.), 48: 471-478, 1998.
46. Lonning, P. E., Helle, S. I., Johannessen, D. C., Adlercreutz, H., Lien, E. A., Tally, M., Ekse, D., Fotsis, T., Anker, G, B., and Hall, K. Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients. Clin. Endocrinol. (Oxf.), 42: 23-30, 1995.
47. Erfurth, E. M., Hagmar, L. E., Saaf, M., and Hall, K. Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein 1 correlate with serum free testosterone and sex hormone binding globulin levels in healthy young and middle-aged men. Clin. Endocrinol. (Oxf.), 44: 659-664, 1996.
48. Yu, H., and Rohan, T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. (Bethesda), 92: 1472-1489, 2000.
49. Muti, P., Quattrin, T., Grant, B. J., Krogh, V., Micheli, A., Schunemann, H. J., Ram, M., Freudenheim, J. L., Sieri, S., Trevisan, M., and Berrino, F. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol. Biomark. Prev., 11: 1361-1368, 2002.
50. Yu, H., Jin, F., Shu, X. O., Li, B. D., Dai, Q., Cheng, J. R., Berkel, H. J., and Zheng, W. Insulin-like growth factors and breast cancer risk in Chinese women. Cancer Epidemiol. Biomark. Prev., 11: 705-712, 2002.